publication venue for
- More than 9 years of continuous trastuzumab treatment in metastatic breast cancer without cardiac toxicity: a case report and literature review. 2014
- 3,6-Disubstituted 1,2,4-Triazolo[3,4-b]Thiadiazoles with Anticancer Activity Targeting Topoisomerase II Alpha.. 13. 2020
- First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma.. 8. 2015
- Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients.. 8. 2015
- Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature.. 7. 2014
- A rehabilitation program for lung cancer patients during postthoracotomy chemotherapy.. 7. 2014
- Targeted therapy in the treatment of malignant gliomas.. 2. 2009
- Emerging role of long non-coding RNAs in cisplatin resistance. 2018
- The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers. 2017
- Ganetespib: research and clinical development. 2015
- Microtubule inhibitor-based antibody-drug conjugates for cancer therapy. 2014
- Evaluating Elacestrant in the Management of ER-Positive, HER2-Negative Advanced Breast Cancer: Evidence to Date. 2023
- Targeted Therapy for Locally Advanced or Metastatic Urothelial Cancer (mUC): Therapeutic Potential of Sacituzumab Govitecan. 2022
- Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets. 2021
- Pembrolizumab for the treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction cancer: an evidence-based review of place in therapy. 2018